vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and Sprout Social, Inc. (SPT). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $120.9M, roughly 1.4× Sprout Social, Inc.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 12.9%). Over the past eight quarters, Sprout Social, Inc.'s revenue compounded faster (11.8% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Sprout Social, Inc. is a technology company that runs a social media management platform. A public company headquartered in Chicago, it was founded in 2010 by Justyn Howard, Aaron Rankin, Gil Lara, and Peter Soung.
ESPR vs SPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $120.9M |
| Net Profit | — | — |
| Gross Margin | — | 77.6% |
| Operating Margin | 50.6% | -9.0% |
| Net Margin | — | — |
| Revenue YoY | 143.7% | 12.9% |
| Net Profit YoY | — | — |
| EPS (diluted) | $0.32 | $-0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $168.4M | $120.9M | ||
| Q3 25 | $87.3M | $115.6M | ||
| Q2 25 | $82.4M | $111.8M | ||
| Q1 25 | $65.0M | $109.3M | ||
| Q4 24 | $69.1M | $107.1M | ||
| Q3 24 | $51.6M | $102.6M | ||
| Q2 24 | $73.8M | $99.4M | ||
| Q1 24 | $137.7M | $96.8M |
| Q4 25 | — | — | ||
| Q3 25 | $-31.3M | $-9.4M | ||
| Q2 25 | $-12.7M | $-12.0M | ||
| Q1 25 | $-40.5M | $-11.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-29.5M | $-17.1M | ||
| Q2 24 | $-61.9M | $-16.9M | ||
| Q1 24 | $61.0M | $-13.6M |
| Q4 25 | — | 77.6% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 77.7% | ||
| Q1 25 | — | 77.3% | ||
| Q4 24 | — | 78.1% | ||
| Q3 24 | — | 77.4% | ||
| Q2 24 | — | 77.5% | ||
| Q1 24 | — | 76.8% |
| Q4 25 | 50.6% | -9.0% | ||
| Q3 25 | -11.4% | -7.9% | ||
| Q2 25 | 8.6% | -11.0% | ||
| Q1 25 | -34.0% | -10.2% | ||
| Q4 24 | -6.4% | -12.8% | ||
| Q3 24 | -31.0% | -16.4% | ||
| Q2 24 | 3.5% | -16.6% | ||
| Q1 24 | 52.5% | -13.7% |
| Q4 25 | — | — | ||
| Q3 25 | -35.9% | -8.1% | ||
| Q2 25 | -15.4% | -10.7% | ||
| Q1 25 | -62.2% | -10.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | -57.2% | -16.6% | ||
| Q2 24 | -83.9% | -17.0% | ||
| Q1 24 | 44.3% | -14.0% |
| Q4 25 | $0.32 | $-0.18 | ||
| Q3 25 | $-0.16 | $-0.16 | ||
| Q2 25 | $-0.06 | $-0.21 | ||
| Q1 25 | $-0.21 | $-0.19 | ||
| Q4 24 | $-0.14 | $-0.25 | ||
| Q3 24 | $-0.15 | $-0.30 | ||
| Q2 24 | $-0.33 | $-0.30 | ||
| Q1 24 | $0.34 | $-0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $95.3M |
| Total DebtLower is stronger | — | $40.0M |
| Stockholders' EquityBook value | $-302.0M | $203.4M |
| Total Assets | $465.9M | $523.1M |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $167.9M | $95.3M | ||
| Q3 25 | $92.4M | $90.6M | ||
| Q2 25 | $86.1M | $101.5M | ||
| Q1 25 | $114.6M | $100.9M | ||
| Q4 24 | $144.8M | $86.4M | ||
| Q3 24 | $144.7M | $82.9M | ||
| Q2 24 | $189.3M | $80.9M | ||
| Q1 24 | $226.6M | $69.2M |
| Q4 25 | — | $40.0M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $25.0M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-302.0M | $203.4M | ||
| Q3 25 | $-451.4M | $194.1M | ||
| Q2 25 | $-433.5M | $184.6M | ||
| Q1 25 | $-426.2M | $175.3M | ||
| Q4 24 | $-388.7M | $166.6M | ||
| Q3 24 | $-370.2M | $158.1M | ||
| Q2 24 | $-344.2M | $152.1M | ||
| Q1 24 | $-294.3M | $147.3M |
| Q4 25 | $465.9M | $523.1M | ||
| Q3 25 | $364.0M | $481.4M | ||
| Q2 25 | $347.1M | $422.9M | ||
| Q1 25 | $324.0M | $424.7M | ||
| Q4 24 | $343.8M | $428.3M | ||
| Q3 24 | $314.1M | $388.8M | ||
| Q2 24 | $352.3M | $393.6M | ||
| Q1 24 | $373.1M | $389.9M |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.15× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | $10.9M |
| Free Cash FlowOCF − Capex | — | $9.9M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | 0.0% | 0.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $39.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $45.2M | $10.9M | ||
| Q3 25 | $-4.3M | $9.3M | ||
| Q2 25 | $-31.4M | $5.1M | ||
| Q1 25 | $-22.6M | $18.1M | ||
| Q4 24 | $-35.0M | $4.1M | ||
| Q3 24 | $-35.3M | $9.0M | ||
| Q2 24 | $-7.2M | $2.1M | ||
| Q1 24 | $53.8M | $11.2M |
| Q4 25 | — | $9.9M | ||
| Q3 25 | — | $8.5M | ||
| Q2 25 | — | $4.2M | ||
| Q1 25 | — | $16.7M | ||
| Q4 24 | — | $3.3M | ||
| Q3 24 | $-35.5M | $8.5M | ||
| Q2 24 | $-7.3M | $1.6M | ||
| Q1 24 | $53.8M | $10.1M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 7.4% | ||
| Q2 25 | — | 3.7% | ||
| Q1 25 | — | 15.3% | ||
| Q4 24 | — | 3.0% | ||
| Q3 24 | -68.7% | 8.3% | ||
| Q2 24 | -9.9% | 1.6% | ||
| Q1 24 | 39.0% | 10.4% |
| Q4 25 | 0.0% | 0.9% | ||
| Q3 25 | 0.0% | 0.7% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.0% | 1.2% | ||
| Q4 24 | 0.0% | 0.8% | ||
| Q3 24 | 0.3% | 0.5% | ||
| Q2 24 | 0.1% | 0.5% | ||
| Q1 24 | 0.1% | 1.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.88× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
SPT
Segment breakdown not available.
